Cantor Fitzgerald Adjusts Healthpeak Properties Price Target to $21 From $23
Cantor Fitzgerald has lowered its price target for Healthpeak Properties, Inc. from $23.00 to $21.00 per share.
Stocks · News reference
Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $19
Wells Fargo analyst James Feldman maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and lowers the price target from $22 to $19.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Healthpeak: 3 Key Takeaways for Long-Term Investors
Healthpeak Properties raised full-year earnings guidance by $0.05 per share following strong Q3 2026 results. The company is acquiring discounted lab buildings near existing campuses with 41% occupancy, targeting 9-10% stabilized yields. Life science lab occupancy increased 270 basis points year-to-date as AI and robotics firms enter the market. Healthpeak recycled nearly $2 billion from outpatient asset sales to fund higher-yielding reinvestments, demonstrating disciplined capital management and positioning itself as a consolidator in major research hubs.
Healthpeak's Q3 FFOA Beat Estimates on Leasing, Senior Housing Growth
Healthpeak Properties (DOC) reported Q3 2026 FFOA of $0.44 per share, beating estimates by 2.3%, with revenues up 16.3% YoY to $820.9 million. The company raised 2026 FFOA guidance to $1.76-$1.78 per share, supported by solid outpatient leasing, improving lab occupancy, and strong senior housing performance from Janus Living. However, operating expenses surged 30% YoY, and the company carries a Zacks Rank #4 (Sell) rating.
Healthpeak Properties Reports Third Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance
Healthpeak Properties, Inc. announced its financial results for the third quarter ended September 30, 2026, reporting FFO as Adjusted of $0.44 per share and raising its full-year 2026 earnings guidance.
8-K filing — HEALTHPEAK PROPERTIES, INC. (DOC)
Filed: 2026-11-02 AccNo: 0001628280-26-068878 Size: 14 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
UBS Maintains Neutral on Healthpeak Properties, Lowers Price Target to $20
UBS maintains Healthpeak Properties (NYSE:DOC) with a Neutral and lowers the price target from $21.5 to $20.